Regis Resources Ltd (RRL.AX) stock: key figures, P/E, revenue and dividend
Materials · Australia · ISIN AU000000RRL8
Regis Resources Ltd financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 1.65 bn AUD | 2.35 bn AUD |
| Gross profit | 822.00 m AUD | 1.02 bn AUD |
| EBIT | 377.00 m AUD | 999.00 m AUD |
| Net income | 254.00 m AUD | 715.00 m AUD |
| Diluted EPS – continuing operations | 0.33 AUD | 0.94 AUD |
Full history since 1989, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Regis Resources Ltd
Regis Resources Limited, together with its subsidiaries, engages in the exploration, evaluation, and development of gold projects in Australia. The company owns interest in the Duketon gold project located in the North Eastern Goldfields of Western Australia; and the McPhillamys gold project situated in the Central Western region of New South Wales. It also holds interest in the Tropicana Gold Project located to the north-east of Kalgoorlie in Western Australia. Regis Resources Limited was incorporated in 1986 and is based in Subiaco, Australia.
More stocks
- Knife River Corp (KNF)
- Ferrotec (Anhui) Technology Development Co. Ltd. A (301297.SZ)
- Celcuity Inc. (CELC)
- Fastly, Inc. (FSLY)
- Ondas Inc. (ONDS)
- China Railway Construction Heavy Industry Corp Ltd (688425.SS)
- Zhejiang Huazheng New Material (603186.SS)
- Farsoon Technology Co. Ltd. A (688433.SS)
- Anhui Zhongding Sealing Parts Co Ltd (000887.SZ)
- Sparebank 1 Sorost-Norge (SOON.OL)
- Nitto Boseki Co Ltd (3110.T)
- Enliven Therapeutics, Inc. (ELVN)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.